Pharmaceuticals & Healthcare

Publications

Reading Between the Lines of the FTC's Interim Report on Authorized Generics (July 2009)

Motions To Dismiss in the Wake of Iqbal: Law And Semantics In The Twenty-First Century (May 2009)

Rare Criminal Prosecution Highlights Sales of Illegal and Counterfeit Drugs in the United States (April 2009)

Bad Economic Conditions Raise New Concerns Over Price Fixing Claims (March 2009)

Another FTC Challenge to the Settlement of a Brand Name Drug Patent Infringement Case Clarifies Matters - A Bit (February 2009)

Will the E.U. Report on Alleged Competitive Abuses in the Pharmaceutical Industry Prompt Action by the Federal Trade Commission in the U.S.? (December 2008)

New California Appellate Decision Makes Brand Name Drug Manufacturers Potentially Liable for Injuries Suffered by Consumers of Generic Drugs (November 2008)

alert: 2008 FTC Actions in the Drug Industry (October 2008)

Increased Focus on FCPA Enforcement in The Medical Industry Continues With AGA Medical Corporation Settlement (July 2008)

Riegel v. Medtronic, Inc.: What Does it Portend for the Broader Pre-Emption of Common Law Claims Against Drug Manufacturers? (February 2008)

Two Recent Decisions Limit Antitrust Plaintiffs’ Rights To Bring Price-Fixing Claims (January 2007)

Verizon Communications Inc. v. Trinko, No. 02-682 (U.S. January 13, 2004) (February 2004)

U.S. Federal Court Order Closes Pharmacy Offering Drugs From Canada (November 2003)

Articles

Stage-Setting For Circ Split: Generic Drug Preemption? (March 2010)

eDiscovery In The Months Ahead (April 2009)

The Learned Intermediary Doctrine: A Viable and Strong Defense For Pharmaceutical and Medical Device Manufacturers In the Age of Direct-to-Consumer Advertising (August 2008)

The Foreign Plaintiff: Applying the doctrine of forum non conveniens to dismiss cases brought by out-of-state claimants (December 2007)

Will Coronato and Steve Lanza are the authors of a review article available through Westlaw (September 2005)

A Call for Continued State Law Tort Reform: Compliance with FDA Regulations As a Bar to Pharmaceutical Product Liability Litigation (March 2004)

Second Wind: Cover Story by The American Lawyer Magazine (August 2003)

Clinical Trials: Strategies for Sponsor Manufacturers to Minimize the Risk of Litigation (July 2002)

Respond to New Mass Tort Litigation With a Global Strategy: Backed by strong science and a well-organized team, you can prevent tort claimants form creating a new mass tort litigation (January 2001)

White Papers

Are "Authorized Generics" Lawful? (May 2004)

News

OctoPlus Deal (October 2008)

Press Releases

Drug and Medical Device Litigation Expert Joins Hughes Hubbard (August 2008)